TP53 and cancer: To determine whether d16 and mutp53 have synthetic lethal interaction in cancer cells, we expressed mutp53-R175H, mutp53-R273H or WT p53 in p53-null cancer cell line H1299 and measured cell proliferation following d16 treatment.